GlassScriptPrepare for your visit
Michael Ian Sobel
Reproductive Endocrinology · Abington, PA · NPI 1982666343
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$228.53
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 4 by amount.
- Abbvie INC. $99.38
- Organon LLC $51.16
- Merck Sharp & Dohme LLC $39.27
- Ferring Pharmaceuticals INC. $38.72
Drugs and devices associated with these payments
Ganirelix Acetate Pregnyl Follistim Aq Ubrelvy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/362423/michael-ian-sobel